Finance

Lists
1477:HKG
Ocumension Therapeutics
4,94 HK$
+1,65%
(+0,080) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1477...
Open
5,00 HK$
High
5,05 HK$
Low
4,90 HK$
Mkt. cap
4,03 млрд
Avg. vol.
368,14 м.
Volume
365,50 м.
52-wk high
8,94 HK$
52-wk low
4,04 HK$
EPS
-0,19 HK$
No. of employees
608
Open
5,00 HK$
High
5,05 HK$
Low
4,90 HK$
Mkt. cap
4,03 млрд
Avg. vol.
368,14 м.
Volume
365,50 м.
52-wk high
8,94 HK$
52-wk low
4,04 HK$
EPS
-0,19 HK$
No. of employees
608
News stories
From web sources and news partners
About Ocumension Therapeutics
CEO-
Employees608
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
255,16 млн
255,16 млн
211,86 млн
211,86 млн
Cost of goods sold
127,52 млн
127,52 млн
119,10 млн
119,10 млн
Cost of revenue
127,52 млн
127,52 млн
119,10 млн
119,10 млн
Research and development expenses
18,05 млн
18,05 млн
16,40 млн
16,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
121,91 млн
121,91 млн
125,44 млн
125,44 млн
Operating expense
140,33 млн
140,33 млн
142,04 млн
142,04 млн
Total operating expenses
267,85 млн
267,85 млн
261,15 млн
261,15 млн
Operating income
-12,69 млн
-12,69 млн
-49,29 млн
-49,29 млн
Other non operating income
-1,44 млн
-1,44 млн
-252,50 м.
-252,50 м.
EBT including unusual items
-13,22 млн
-13,22 млн
-49,17 млн
-49,17 млн
EBT excluding unusual items
-14,23 млн
-14,23 млн
-50,14 млн
-50,14 млн
Income tax expense
29,00 мың
29,00 мың
333,50 м.
333,50 м.
Effective tax rate
-0,22%
-0,22%
-0,68%
-0,68%
Other operating expenses
-
-
-
-
Net income
-13,25 млн
-13,25 млн
-49,51 млн
-49,51 млн
Net profit margin
-5,19%
-5,19%
-23,37%
-23,37%
Earnings per share
-
-
-
-
Interest and investment income
1,18 млн
1,18 млн
611,50 м.
611,50 м.
Interest expense
-810,50 м.
-810,50 м.
-1,43 млн
-1,43 млн
Net interest expenses
367,50 м.
367,50 м.
-819,00 м.
-819,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
19,94 млн
19,94 млн
-13,14 млн
-13,14 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары